Companies large and small have sought to take on Intuitive in soft-tissue surgical robotics, but it has maintained its dominance.
Intuitive President Dave Rosa will explain how Intuitive plans to continue maintaining distance from its competitors — and much more, during DeviceTalks West next week. Register here for the event, which is Oct. 18–19 in Santa Clara, California.
Rosa has been at Intuitive for nearly 30 years; the company promoted him to the president role in May. Working with CEO Gary Guthart, Rosa’s responsibilities include overseeing core business, driving product, digital and commercial excellence, and delivering on strategies and goals.
Rosa has said that he’s especially excited about two technological opportunities that are going to advance surgical robotics and minimally invasive surgery in a major way: improved visualization for surgeons and focal therapy.
“How can we help surgeons see more about what they’re doing? … That, to me, is a huge piece of the puzzle going forward that I’m really excited about,” Rosa said in an interview with DeviceTalks Editorial Director Tom Salemi for our IntuitiveTalks podcast.
Intuitive is the world’s 22nd-largest medical device manufacturer, according to our latest Medtech Big 100 ranking of device companies by revenue. But focal therapy and imaging technology for robotic surgeries are two reasons why Rosa doesn’t think of Intuitive as a robotics company— and perhaps not even a medical device company — but more of a minimally invasive care company.
DeviceTalks West: Intuitive President Dave Rosa will give a keynote interview in Santa Clara, California on Oct. 19